{"disease":{"id":"chronic-rhinosinusitis","name":"chronic rhinosinusitis"},"drugs":{"marketed":[{"drug_id":"tezepelumab","indication_name":"Inadequately Controlled Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Tezspire","generic_name":"TEZEPELUMAB","company_name":"AstraZeneca / Amgen","drug_phase":"marketed","molecular_target":"","drug_class":"Thymic Stromal Lymphopoietin Blocker [EPC]","quality_score":30,"revenue":null,"mechanism":null}],"pipeline":[{"drug_id":"rimegepant-75-mg","indication_name":"Acute treatment of chronic rhinosinusitis with and without nasal polyps","indication_type":"pipeline","phase":"Phase 3","line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Rimegepant 75 MG","generic_name":"rimegepant-75-mg","company_name":"Pfizer Inc.","drug_phase":"preclinical","molecular_target":"Calcitonin gene-related peptide (CGRP) receptor","drug_class":"CGRP receptor antagonist (gepant)","quality_score":25,"revenue":null,"mechanism":"Rimegepant selectively antagonizes the calcitonin gene-related peptide (CGRP) receptor to block migraine pain signaling."}],"offLabel":[],"totalMarketed":1,"totalPipeline":1},"trials":{"data":[{"nct_id":"NCT05935683","title":"Rhinosinusitis Italian Network: the Italian Registry for Severe, Uncontrolled Chronic Rhinosinusitis","phase":"","overall_status":"RECRUITING","enrollment_count":5000,"lead_sponsor_name":"Italian Academy of Rhinology","has_results":false},{"nct_id":"NCT04670172","title":"Real-Life Chronic Rhinosinusitis Outcome Registry","phase":"","overall_status":"RECRUITING","enrollment_count":4550,"lead_sponsor_name":"Change Accelerator in Respiratory Care","has_results":false},{"nct_id":"NCT06231004","title":"Correlation Between the Microbiome and Type 2 Inflammatory Diseases of CRSwNP","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":1000,"lead_sponsor_name":"The First Affiliated Hospital with Nanjing Medical University","has_results":false},{"nct_id":"NCT06970977","title":"CRS Questionnaire Validation Project","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"The European Forum for Research and Education in Allergy and Airway Diseases","has_results":false},{"nct_id":"NCT03893227","title":"Prevalence of Nasal Hyperreactivity in Chronic Upper Airway Inflammation","phase":"","overall_status":"COMPLETED","enrollment_count":756,"lead_sponsor_name":"Universitaire Ziekenhuizen KU Leuven","has_results":false},{"nct_id":"NCT04959448","title":"Study Assessing Long-teRm Outcomes of dupiluMAb (DUPIXENT®) Treatment in Adult Patients With Chronic Rhinosinusitis With Nasal Polyposis (CRSwNP)","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":717,"lead_sponsor_name":"Regeneron Pharmaceuticals","has_results":false},{"nct_id":"NCT05061329","title":"The Nasal Microbiome and Its Importance in Disease","phase":"","overall_status":"RECRUITING","enrollment_count":619,"lead_sponsor_name":"University of Aarhus","has_results":false},{"nct_id":"NCT05529784","title":"Dupilumab in the Treatment of Severe Uncontrolled CRSwNP: a Multicentre Observational Real-life Study (DUPIREAL)","phase":"","overall_status":"UNKNOWN","enrollment_count":600,"lead_sponsor_name":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","has_results":false},{"nct_id":"NCT02746042","title":"Sinupret Extract Coated Tablets in Chronic Rhinosinusitis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":572,"lead_sponsor_name":"Bionorica SE","has_results":false},{"nct_id":"NCT02898454","title":"Controlled Clinical Study of Dupilumab in Patients With Nasal Polyps","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":448,"lead_sponsor_name":"Sanofi","has_results":true},{"nct_id":"NCT02720653","title":"Determinants of Olfactory Dysfunction in Chronic Rhinosinusitis","phase":"","overall_status":"UNKNOWN","enrollment_count":418,"lead_sponsor_name":"Oregon Health and Science University","has_results":false},{"nct_id":"NCT04851964","title":"Efficacy and Safety of Tezepelumab in Participants With Severe Chronic Rhinosinusitis With Nasal Polyposis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":416,"lead_sponsor_name":"AstraZeneca","has_results":true},{"nct_id":"NCT07424144","title":"An Extension Study to Investigate the Long-term Safety and Tolerability of Itepekimab in Adult Participants With Inadequately Controlled Chronic Rhinosinusitis With Nasal Polyps","phase":"PHASE3","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":380,"lead_sponsor_name":"Sanofi","has_results":false},{"nct_id":"NCT04998604","title":"EValuating trEatment RESponses of Dupilumab Versus Omalizumab in Type 2 Patients","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":360,"lead_sponsor_name":"Sanofi","has_results":true},{"nct_id":"NCT07200336","title":"Anti-IL-5 Therapy With Simple Polypectomy Versus Extended Endoscopic Sinus Surgery for CRSwNP","phase":"PHASE4","overall_status":"NOT_YET_RECRUITING","enrollment_count":360,"lead_sponsor_name":"Eye & ENT Hospital of Fudan University","has_results":false},{"nct_id":"NCT07125586","title":"Real-Time Diagnosis of Eosinophilic Nasal Polyps Using High-Sensitivity Spectroscopy","phase":"NA","overall_status":"RECRUITING","enrollment_count":353,"lead_sponsor_name":"The Affiliated Hospital of Qingdao University","has_results":false},{"nct_id":"NCT03781804","title":"Study Evaluating the Efficacy and Safety of Intranasal Administration of OPN-375 in Subjects With Chronic Rhinosinusitis With or Without the Presence of Nasal Polyps","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":332,"lead_sponsor_name":"Optinose US Inc.","has_results":true},{"nct_id":"NCT07290140","title":"Paclitaxel-Coated Balloon Treatment of Chronic Rhinosinusitis","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":300,"lead_sponsor_name":"Airiver Medical, Inc.","has_results":false},{"nct_id":"NCT04157335","title":"Efficacy and Safety Study of Benralizumab in Patient With Eosinophilic Chronic Rhinosinusitis With Nasal Polyps (ORCHID)","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":295,"lead_sponsor_name":"AstraZeneca","has_results":true},{"nct_id":"NCT04131686","title":"NAC Inhalation in the Treatment Of Symptomatic acuTe rhinosinUSitis","phase":"","overall_status":"COMPLETED","enrollment_count":294,"lead_sponsor_name":"Boryung Pharmaceutical Co., Ltd","has_results":true},{"nct_id":"NCT06013241","title":"A Study of the Efficacy and Safety of Brensocatib in Participants With Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":288,"lead_sponsor_name":"Insmed Incorporated","has_results":false},{"nct_id":"NCT02912468","title":"A Controlled Clinical Study of Dupilumab in Patients With Bilateral Nasal Polyps","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":276,"lead_sponsor_name":"Sanofi","has_results":true},{"nct_id":"NCT05248997","title":"Safety and Efficacy of BHV-3000 (Rimegepant) Orally Disintegrating Tablet for the Acute Treatment of Chronic Rhinosinusitis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":261,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT02347943","title":"Global Sinus Surgery Registry","phase":"","overall_status":"TERMINATED","enrollment_count":252,"lead_sponsor_name":"Integra LifeSciences Corporation","has_results":true},{"nct_id":"NCT03478930","title":"An Extension Study of Omalizumab in Participants With Chronic Rhinosinusitis With Nasal Polyps","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":249,"lead_sponsor_name":"Hoffmann-La Roche","has_results":true},{"nct_id":"NCT07520162","title":"A Study to Investigate NPS and Symptoms in Chinese Adult Participants With CRSwNP Initiating Treatment With Tezepelumab","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":230,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT03960580","title":"Study Evaluating the Efficacy and Safety of Intranasal Administration of OPN-375 in Subjects With Chronic Rhinosinusitis Without the Presence of Nasal Polyps","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":223,"lead_sponsor_name":"Optinose US Inc.","has_results":true},{"nct_id":"NCT05942222","title":"A Real-world, Head-to-head Comparison of Dupilumab Versus Mepolizumab in Danish Patients With Chronic Rhinosinusitis With Nasal Polyps","phase":"PHASE4","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":220,"lead_sponsor_name":"Rigshospitalet, Denmark","has_results":false},{"nct_id":"NCT05925985","title":"Propel Drug-Eluting Sinus Stent Family Open Cohort","phase":"","overall_status":"COMPLETED","enrollment_count":215,"lead_sponsor_name":"Medtronic","has_results":false},{"nct_id":"NCT06837051","title":"The Effect of Modified Olfactory Training on Postoperative Olfactory Dysfunction in Patients With CRS","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":213,"lead_sponsor_name":"Peking University Third Hospital","has_results":false},{"nct_id":"NCT07420257","title":"A Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy and Safety of CM326 in Participants With Chronic Rhinosinusitis With Nasal Polyposis","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":212,"lead_sponsor_name":"CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT06834360","title":"A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polyps","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":210,"lead_sponsor_name":"Sanofi","has_results":false},{"nct_id":"NCT06834347","title":"A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polyps","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":210,"lead_sponsor_name":"Sanofi","has_results":false},{"nct_id":"NCT07446738","title":"A Study to Investigate the Clinical Outcome and Quality of Life in Chinese Post-operative CRSwNP Patients","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":200,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT06010316","title":"A Prospective Single-center Cohort Study of Surgical Treatment of Chronic Rhinosinusitis","phase":"","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"Beijing Tongren Hospital","has_results":false},{"nct_id":"NCT06118554","title":"3D Printing to Improve Nasal Irrigation Outcome","phase":"NA","overall_status":"RECRUITING","enrollment_count":200,"lead_sponsor_name":"Ohio State University","has_results":false},{"nct_id":"NCT06258772","title":"Mepolizumab in the Treatment of Patients With Severe Uncontrolled CRSwNP: a Multicentric Real Life Observational Study","phase":"","overall_status":"UNKNOWN","enrollment_count":199,"lead_sponsor_name":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","has_results":false},{"nct_id":"NCT05219968","title":"Efficacy and Safety of LYR-210 for the Treatment of Chronic Rhinosinusitis in Adults","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":196,"lead_sponsor_name":"Lyra Therapeutics","has_results":true},{"nct_id":"NCT07498374","title":"Efficacy and Safety of Fully Resorbable Sinus Drug-eluting Stents in Patients With Eosinophilic Chronic Rhinosinusitis With Nasal Polyps After Surgery: A Prospective, Randomized Controlled Trial","phase":"NA","overall_status":"RECRUITING","enrollment_count":192,"lead_sponsor_name":"Tang-Du Hospital","has_results":false},{"nct_id":"NCT05295459","title":"Efficacy and Safety of LYR-210 for the Treatment of Chronic Rhinosinusitis in Adults (ENLIGHTEN 2)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":182,"lead_sponsor_name":"Lyra Therapeutics","has_results":true},{"nct_id":"NCT05436275","title":"A Study of CM310 in Patients With Chronic Rhinosinusitis With Nasal Polyposis （CROWNS-2）","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":180,"lead_sponsor_name":"Keymed Biosciences Co.Ltd","has_results":false},{"nct_id":"NCT05938972","title":"Real Life Study of Biologicals in Patients With Severe CRSwNP","phase":"","overall_status":"RECRUITING","enrollment_count":180,"lead_sponsor_name":"University Hospital, Ghent","has_results":false},{"nct_id":"NCT07383402","title":"Intra-Sinus Povidone-Iodine and Budesonide After Endoscopic Sinus Surgery for Chronic Rhinosinusitis","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":180,"lead_sponsor_name":"Amin Javer","has_results":false},{"nct_id":"NCT06706817","title":"A Study to Investigate Changes in Symptoms in Adult Participants With Chronic Rhinosinusitis With Nasal Polyposis Initiating Treatment With Tezepelumab","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":180,"lead_sponsor_name":"AstraZeneca","has_results":false},{"nct_id":"NCT04469439","title":"Impact of Sinus Surgery on Individuals With Cystic Fibrosis","phase":"","overall_status":"RECRUITING","enrollment_count":170,"lead_sponsor_name":"University of California, Los Angeles","has_results":false},{"nct_id":"NCT06393946","title":"Study in Adults With Severe Chronic Rhinosinusitis With Nasal Polyposis Treated With Dupilumab in France","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":150,"lead_sponsor_name":"Sanofi","has_results":false},{"nct_id":"NCT07313917","title":"A Study to Evaluate the Efficacy and Safety of LP-003 Injection in Patients With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":150,"lead_sponsor_name":"Longbio Pharma","has_results":false},{"nct_id":"NCT05598424","title":"CST1 Predictive Model of Oral Glucocorticoid Therapy Sensitivity for Chronic Rhinosinusitis With Polyps","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":150,"lead_sponsor_name":"Beijing Tongren Hospital","has_results":false},{"nct_id":"NCT04093193","title":"Debridement and Functional Endoscopic Sinus Surgery","phase":"NA","overall_status":"UNKNOWN","enrollment_count":150,"lead_sponsor_name":"St. Paul's Hospital, Canada","has_results":false},{"nct_id":"NCT05649813","title":"A Study in Male and Female Adult Participants With Chronic Rhinosinusitis With Nasal Polyps In the Greater Gulf Region","phase":"","overall_status":"COMPLETED","enrollment_count":148,"lead_sponsor_name":"Sanofi","has_results":false}],"total":50},"guidelines":[],"source":"Drug Landscape verified database"}